Meiji Yasuda Life Insurance Co acquired a new stake in KKR & Co. Inc. (NYSE:KKR) during the fourth quarter, according to the company’s latest SEC disclosure. The firm purchased 5,040 shares of the asset manager’s stock, valued at approximately $745,000.
This investment was part of a broader trend among institutional investors. Several other firms also modified their holdings in KKR during the same period. Keel Point LLC increased its stake by 28.4%, now owning 5,478 shares valued at $810,000. Other investors, including Davidson Kahn Capital Management LLC, Bison Wealth LLC, Becker Capital Management Inc., and Voleon Capital Management LP, also acquired new positions in KKR, with investments ranging from $210,000 to $2,174,000.
Institutional investors collectively own 76.26% of KKR’s stock. In related news, major shareholder Genetic Disorder L.P. Kkr sold 6,000,000 shares on March 5th at an average price of $32.96, reducing their stake by 23.75%. Corporate insiders currently own 39.34% of the company’s stock.
KKR has been the subject of various research reports. Hsbc Global Res upgraded KKR from ‘hold’ to ‘strong-buy’ on April 15th. Other analysts from Bank of America, TD Cowen, Keefe, Bruyette & Woods, and Citigroup have also issued reports with ‘buy’ or ‘outperform’ ratings, although some have adjusted their price targets. The consensus rating is ‘Moderate Buy’ with a target price of $144.33.
KKR’s stock performance has been notable, opening at $117.00 on Friday. The company has a market cap of $103.93 billion and a price-to-earnings ratio of 35.14. KKR reported $1.15 earnings per share for the quarter ending May 1st, exceeding analysts’ expectations. The company also announced a quarterly dividend of $0.175 per share, representing an annualized dividend yield of 0.60%.
